Anne-Kristina Mercier

6PUBLICATIONS
23CO-AUTHORS
Biologically active moleculesAllergyFood properties (incl. characteristics and health benefits)Pharmaceutical delivery technologiesFoetal development and medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 30, 2026
Next-generation therapeutics and renaissance of legacy drugs targeting the endothelin system.

|Aug 30, 2025
AZD0449, an inhaled JAK1 inhibitor, in healthy participants and patients with mild asthma.

Anna Lundahl, Rod Hughes, Joachim Almquist

|Oct 01, 2024
Effects of Zibotentan Alone and in Combination with Dapagliflozin on Fluid Retention in Patients with CKD.

J David Smeijer, Victor S Wasehuus, Neeraj Dhaun

|Jul 04, 2024
From Plan to Pivot: How Model-Informed Drug Development Shaped the Dose Strategy of the Zibotentan/Dapagliflozin ZENITH Trials.

Anne-Kristina Mercier, Sebastian Ueckert, Mikael Sunnåker

|Apr 30, 2024
Zibotentan Can Be Co-administered with Contraceptives Containing Ethinyl Estradiol and Levonorgestrel: A Pharmacokinetic Drug-Drug Interaction Study.

Anne-Kristina Mercier, Abigail K Kois, Deeyen Karsanji

|Oct 06, 2023
Pharmacokinetics and Tolerability of Zibotentan in Patients with Concurrent Moderate Renal and Moderate Hepatic Impairment.

Anne-Kristina Mercier, Mikael Sunnåker, Sebastian Ueckert

Pageof 1

Frequent Collaborators

3 joint publications

Philip Ambery

3 joint publications

Peter J Greasley

3 joint publications

Magnus Åstrand

1 joint publications

Deeyen Karsanji